Department of Mass Spectrometry, LGC, Queens Road, Teddington, London, TW11 0LY, United Kingdom.
Protein Sci. 2010 Apr;19(4):826-35. doi: 10.1002/pro.362.
Oxidation of methionine residues in biopharmaceuticals is a common and often unwanted modification that frequently occurs during their manufacture and storage. It often results in a lack of stability and biological function of the product, necessitating continuous testing for the modification throughout the product shelf life. A major class of biopharmaceutical products are monoclonal antibodies (mAbs), however, techniques for their detailed structural analysis have until recently been limited. Hydrogen/deuterium exchange mass spectrometry (HXMS) has recently been successfully applied to the analysis of mAbs. Here we used HXMS to identify and localise the structural changes that occurred in a mAb (IgG1) after accelerated oxidative stress. Structural alterations in a number of segments of the Fc region were observed and these related to oxidation of methionine residues. These included a large change in the hydrogen exchange profile of residues 247-253 of the heavy chain, while smaller changes in hydrogen exchange profile were identified for peptides that contained residues in the interface of the C(H)2 and C(H)3 domains.
在生物制药中,蛋氨酸残基的氧化是一种常见且通常不受欢迎的修饰,这种修饰在其生产和储存过程中经常发生。它通常会导致产品缺乏稳定性和生物功能,因此需要在产品保质期内持续检测修饰情况。单克隆抗体(mAb)是一类主要的生物制药产品,然而,其详细结构分析技术直到最近才受到限制。氢/氘交换质谱(HXMS)最近已成功应用于 mAb 的分析。在这里,我们使用 HXMS 来确定和定位 mAb(IgG1)在加速氧化应激后发生的结构变化。在 Fc 区域的多个片段中观察到结构改变,这些改变与蛋氨酸残基的氧化有关。其中包括重链 247-253 位残基的氢交换谱的大幅变化,而在 C(H)2 和 C(H)3 结构域界面残基的肽中则发现较小的氢交换谱变化。